approval · primary record
ASENAPINE
FDA · NDA · 2025-01-22
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-01-22 |
| Brand | SECUADO |
| Sponsor | HISAMITSU |
| Route | TRANSDERMAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:42.120Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ASENAPINE:2025-01-22
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.